has been critical of the drug as a weight loss method, saying that it focuses on symptoms of obesity rather than fixing what he classifies as root problems, such as food systems and exercise
May your electrolytes stay balanced, your energy stay steady, and your GLP-1 results stay on track.
Severe insulin deficiency represents a significant limitationpatients with longstanding type 2 diabetes who have substantial beta-cell dysfunction may not respond adequately to GLP-1 receptor agonists alone, as these medications work by enhancing glucose-dependent insulin secretion
Thousands of lawsuits have been filed against the manufacturers for allegedly failing to warn about these risks, prioritizing profits over consumer safety
GLP-1 receptor agonists increase resting heart rate
It has not yet been approved for medical use in the UK, EU, or US for weight loss purposes and therefore cannot be recommended as safe and effective at this time